SynthesisBlood cancer journal2022

Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis.

Noppacharn Uaprasert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.